Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children
- PMID: 19615660
- PMCID: PMC2758816
- DOI: 10.1016/j.tripleo.2009.05.008
Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children
Abstract
Objectives: The aim was to examine the impact of antiretroviral therapy on the prevalence of oral candidiasis, recovery of oral Candida spp. , and salivary levels of total secretory immunoglobulin A (SIgA) and Candida-specific SIgA in human immunodeficiency virus (HIV)-infected children.
Study design: Sixty-six HIV+ and 40 HIV- children were cross-sectionally examined for the presence of oral lesions. Whole stimulated saliva samples were collected for the identification of Candida spp. using culture and measurement of total and specific SIgA using enzyme-linked immunosorbent assay (ELISA).
Results: The HIV+ children had a higher prevalence of oral candidiasis (P < .05), higher frequency of detection of Candida spp. (P < .05), and higher levels of total (P < .05) and Candida-specific SIgA (P < .001) than the HIV- children. Among the HIV+ subjects, antiretroviral users had lower viral loads (P < .001) and lower levels of Candida spp. (P < .05) and total SIgA (P < .05) compared with antiretroviral nonusers.
Conclusions: The use of antiretroviral therapy was associated with decreases in the prevalence of oral candidiasis. This diminished exposure to Candida spp. was accompanied by decreases in levels of total and Candida-specific SIgA.
Similar articles
-
Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.J Oral Pathol Med. 2010 Feb;39(2):188-94. doi: 10.1111/j.1600-0714.2009.00857.x. Epub 2009 Dec 22. J Oral Pathol Med. 2010. PMID: 20040023
-
Salivary lactoferrin in HIV-infected children: correlation with Candida albicans carriage, oral manifestations, HIV infection and its antifungal activity.Arch Oral Biol. 2014 Aug;59(8):775-82. doi: 10.1016/j.archoralbio.2014.04.010. Epub 2014 Apr 21. Arch Oral Biol. 2014. PMID: 24837476
-
Pseudomembranous Type of Oral Candidiasis is Associated with Decreased Salivary Flow Rate and Secretory Immunoglobulin A Levels.Mycopathologia. 2015 Aug;180(1-2):75-80. doi: 10.1007/s11046-015-9874-5. Epub 2015 Feb 15. Mycopathologia. 2015. PMID: 25682023
-
Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy era. A literature analysis.Int J STD AIDS. 2015 Aug;26(9):625-32. doi: 10.1177/0956462414548906. Epub 2014 Aug 25. Int J STD AIDS. 2015. PMID: 25156369 Review.
-
Oropharyngeal Candida colonization in human immunodeficiency virus infected patients.APMIS. 2013 May;121(5):375-402. doi: 10.1111/apm.12006. Epub 2012 Sep 25. APMIS. 2013. PMID: 23030258 Review.
Cited by
-
Photodynamic inactivation of biofilms formed by Candida spp., Trichosporon mucoides, and Kodamaea ohmeri by cationic nanoemulsion of zinc 2,9,16,23-tetrakis(phenylthio)-29H, 31H-phthalocyanine (ZnPc).Lasers Med Sci. 2012 Nov;27(6):1205-12. doi: 10.1007/s10103-012-1050-2. Epub 2012 Jan 26. Lasers Med Sci. 2012. PMID: 22278349
-
Effect of CD4+ lymphocyte count, viral load, and duration of taking anti-retroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS.Eur Arch Paediatr Dent. 2010 Oct;11(5):242-6. doi: 10.1007/BF03262755. Eur Arch Paediatr Dent. 2010. PMID: 20932399
-
Quantification of Oral Candidal Carriage Rate and Prevalence of Oral Candidal Species in HIV Patients with and Without Highly Active Antiretroviral Therapy.J Microsc Ultrastruct. 2021 Dec 9;9(4):145-153. doi: 10.4103/JMAU.JMAU_32_19. eCollection 2021 Oct-Dec. J Microsc Ultrastruct. 2021. PMID: 35070688 Free PMC article.
-
Recent mouse and rat methods for the study of experimental oral candidiasis.Virulence. 2013 Jul 1;4(5):391-9. doi: 10.4161/viru.25199. Epub 2013 May 28. Virulence. 2013. PMID: 23715031 Free PMC article. Review.
-
Oral Health Status of Children and Adolescents Living with HIV Undergoing Antiretroviral Therapy: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health. 2022 Oct 8;19(19):12864. doi: 10.3390/ijerph191912864. Int J Environ Res Public Health. 2022. PMID: 36232165 Free PMC article.
References
-
- Greenspan D, Greenspan JS. Oral manifestations of HIV infection. AIDS Clin Care. 1997;9:29–33. - PubMed
-
- Ramos-Gomez FJ, Petru A, Hilton JF, Canchola AJ, Wara D, Greenspan JS. Oral manifestations and dental status in paediatric HIV infection. Int J Paediatr Dent. 2000;10:3–11. - PubMed
-
- Blanchard A, Montagnier L, Gougeon ML. Influence of microbial infections on the progression of HIV disease. Trends Microbiol. 1997;5:326–331. - PubMed
-
- Grimoud AM, Arnaud C, Dellamonica P, Lodter JP. Salivary defence factor concentrations in relation to oral and general parameters in HIV positive patients. Eur J Oral Sci. 1998;106:979–985. - PubMed
-
- Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med. 1984;311:354–358. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous